Tin tức & Cập nhật
Xem bài viết Gan
Xem
Chỉ hiển thị Multimedia

Empagliflozin reduces hepatic fat content in nondiabetic MASLD patients
02 Sep 2024
bởiChristina Lau
Empagliflozin significantly reduces hepatic fat content vs placebo in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) without diabetes, researchers from the University of Hong Kong have reported.
02 Sep 2024

Simple tests predict liver stiffness in people living with HIV, liver disease
22 Aug 2024
A recent study has noted the excellent specificity and negative predictive value of FIB-4 and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) in diagnosing advanced fibrosis (AF, bridging fibrosis or cirrhosis) among people living with HIV (PWH).
22 Aug 2024

Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
17 Aug 2024
bởiStephen Padilla
The incidence of cirrhosis and hepatocellular carcinoma (HCC) among veterans differs according to demographic and clinical characteristics, with the lowest rate seen among Asians, reports a study.
17 Aug 2024






